Sign in

CIK 0001662579

  • Non-accelerated filer
  • Smaller reporting company

C4 Therapeutics, Inc.

Sign in to watch
Ticker
CCCC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
475617627
Phone
+1 617-231-0700
Business address
490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$122,487
in 1 filing, $122K under 10b5-1 plans

Net −$122,487. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Adams Kendra −$122K Chief Financial Officer sold 12% of stake
Date Insider Transaction Shares Price Value Owned after
2026-02-14 Mahaney Paige Chief Scientific Officer Option exercise +7,050 339,356
2026-02-14 Mahaney Paige Chief Scientific Officer Shares withheld for taxes −2,446 $1.89 $5K 336,910
2026-02-13 Mahaney Paige Chief Scientific Officer Grant or award +240,000 339,356
2025-10-28 Mahaney Paige Chief Scientific Officer Option exercise +19,200 105,000
2025-10-28 Mahaney Paige Chief Scientific Officer Shares withheld for taxes −5,644 $2.58 $15K 99,356
2025-02-14 Mahaney Paige Chief Scientific Officer Grant or award +28,200 105,000
2025-02-14 Mahaney Paige Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +42,400 42,400
2024-10-28 Mahaney Paige Chief Scientific Officer Grant or award +76,800 76,800
2024-10-28 Mahaney Paige Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +345,600 345,600

Page 1 of 1 · 9 trades